Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 74 articles: HTML format Text format

Single Articles

June 2018
1. HAMDY S, Osman AM, Zakaria ZA, Galal I, et al
   Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
   Arch Virol. 2018 Jun 2. pii: 10.1007/s00705-018-3893.
   PubMed     Text format     Abstract available
   
   
   
2. TAJIK Z, Bokharaei-Salim F, Ghorbani S, Keyvani H, et al
   Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
   Arch Virol. 2018;163:1559-1566.
   PubMed     Text format     Abstract available
   
   
   March 2018
3. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
   Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
   Arch Virol. 2018 Mar 24. pii: 10.1007/s00705-018-3798.
   PubMed     Text format     Abstract available
   
   
   
4. FRAGOSO-FONSECA DE, Escobar-Escamilla N, Lloret Y Sanchez LT, Wong-Arambula CE, et al
   Full genome and phylogenetic analysis of hepatitis B virus genotype F in Mexican isolates.
   Arch Virol. 2018 Mar 16. pii: 10.1007/s00705-018-3813.
   PubMed     Text format     Abstract available
   
   
   February 2018
5. MOZHGANI SH, Malekpour SA, Norouzi M, Ramezani F, et al
   Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
   Arch Virol. 2018 Feb 13. pii: 10.1007/s00705-018-3764.
   PubMed     Text format     Abstract available
   
   
   
6. WANG H, Xin X, Wang M, Han L, et al
   Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activation.
   Arch Virol. 2018 Feb 7. pii: 10.1007/s00705-018-3748.
   PubMed     Text format     Abstract available
   
   
   
7. BEHZADIFAR M, Gorji HA, Bragazzi NL
   The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis.
   Arch Virol. 2018 Feb 6. pii: 10.1007/s00705-018-3767.
   PubMed     Text format     Abstract available
   
   
   
8. PRIMADHARSINI PP, Mulyanto, Wibawa IDN, Anggoro J, et al
   The identification and characterization of novel rat hepatitis E virus strains in Bali and Sumbawa, Indonesia.
   Arch Virol. 2018 Feb 5. pii: 10.1007/s00705-018-3736.
   PubMed     Text format     Abstract available
   
   
   
9. ZHU DY, Deng XZ, Zhu YM, Li GT, et al
   Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.
   Arch Virol. 2018 Feb 5. pii: 10.1007/s00705-018-3750.
   PubMed     Text format     Abstract available
   
   
   January 2018
10. YU JM, Li LL, Xie GC, Zhang CY, et al
    Experimental infection of Marmota monax with a novel hepatitis A virus.
    Arch Virol. 2018 Jan 31. pii: 10.1007/s00705-018-3715.
    PubMed     Text format     Abstract available
    
    
    
11. NAEEMI H, Aslam R, Raza SM, Shahzad MA, et al
    Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
    Arch Virol. 2018 Jan 16. pii: 10.1007/s00705-018-3711.
    PubMed     Text format     Abstract available
    
    
    
12. YAN Y, Li C, Sun B, Yang R, et al
    DCAF1 is involved in HCV replication through regulation of miR-122.
    Arch Virol. 2018 Jan 11. pii: 10.1007/s00705-017-3691.
    PubMed     Text format     Abstract available
    
    
    
13. BOGLIONE L, Cusato J, Pinna SM, De Nicolo A, et al
    Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
    Arch Virol. 2018 Jan 9. pii: 10.1007/s00705-017-3684.
    PubMed     Text format     Abstract available
    
    
    December 2017
14. ISHIBASHI M, Yamaguchi H, Hirotani Y, Sakurada A, et al
    Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
    Arch Virol. 2017 Dec 16. pii: 10.1007/s00705-017-3675.
    PubMed     Text format     Abstract available
    
    
    
15. HARA J, Tanaka Y, Kaneko H, Itoh Y, et al
    Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains.
    Arch Virol. 2017 Dec 2. pii: 10.1007/s00705-017-3665.
    PubMed     Text format     Abstract available
    
    
    November 2017
16. SILVA FQ, Santos FJA, Andrade AP, Pacheco SDB, et al
    Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.
    Arch Virol. 2017 Nov 21. doi: 10.1007/s00705-017-3656.
    PubMed     Text format     Abstract available
    
    
    
17. YANG S, Xing H, Feng S, Ju W, et al
    Prevalence of NS5B resistance-associated variants in treatment-naive Asian patients with chronic hepatitis C.
    Arch Virol. 2017 Nov 15. doi: 10.1007/s00705-017-3640.
    PubMed     Text format     Abstract available
    
    
    
18. GORI A, Gheorgita S, Spinu C, Pinzaru I, et al
    Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.
    Arch Virol. 2017 Nov 8. doi: 10.1007/s00705-017-3632.
    PubMed     Text format     Abstract available
    
    
    
19. DE MIRANDA BKB, de Sa KSG, da Silva ANR, Feitosa RNM, et al
    GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count.
    Arch Virol. 2017;162:3431-3438.
    PubMed     Text format     Abstract available
    
    
    October 2017
20. BADFAR G, Shohani M, Nasirkandy MP, Mansouri A, et al
    Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis.
    Arch Virol. 2017 Oct 23. doi: 10.1007/s00705-017-3551.
    PubMed     Text format     Abstract available
    
    
    
21. NGUYEN LT, Van Nguyen D, Carr MJ, Hall WW, et al
    Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Arch Virol. 2017 Oct 11. doi: 10.1007/s00705-017-3583.
    PubMed     Text format     Abstract available
    
    
    
22. ABD-ELSALAM S, Sharaf-Eldin M, Soliman S, Elfert A, et al
    Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Arch Virol. 2017 Oct 5. doi: 10.1007/s00705-017-3573.
    PubMed     Text format     Abstract available
    
    
    September 2017
23. FERREIRA AC, Gomes-Gouvea MS, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.
    Arch Virol. 2017 Sep 30. doi: 10.1007/s00705-017-3562.
    PubMed     Text format     Abstract available
    
    
    
24. RAMIREZ-SOTO MC, Bracho MA, Gonzalez-Candelas F, Huichi-Atamari M, et al
    Genotypes and subgenotypes of hepatitis B virus circulating in an endemic area in Peru.
    Arch Virol. 2017 Sep 25. doi: 10.1007/s00705-017-3557.
    PubMed     Text format     Abstract available
    
    
    
25. PONDE RAA
    The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.
    Arch Virol. 2017 Sep 7. doi: 10.1007/s00705-017-3538.
    PubMed     Text format     Abstract available
    
    
    July 2017
26. YOUSSEF SS, Hamdy NM
    SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.
    Arch Virol. 2017 Jul 31. doi: 10.1007/s00705-017-3498.
    PubMed     Text format     Abstract available
    
    
    
27. DAUD M, Rana MA, Husnain T, Ijaz B, et al
    Modulation of Wnt signaling pathway by hepatitis B virus.
    Arch Virol. 2017 Jul 6. doi: 10.1007/s00705-017-3462.
    PubMed     Text format     Abstract available
    
    
    June 2017
28. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2017 Jun 22. doi: 10.1007/s00705-017-3449.
    PubMed     Text format     Abstract available
    
    
    
29. QU C, Xu L, Yin Y, Peppelenbosch MP, et al
    Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
    Arch Virol. 2017 Jun 16. doi: 10.1007/s00705-017-3444.
    PubMed     Text format     Abstract available
    
    
    
30. LI S, Xie M, Li W, Peng Q, et al
    Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China.
    Arch Virol. 2017 Jun 9. doi: 10.1007/s00705-017-3437.
    PubMed     Text format     Abstract available
    
    
    May 2017
31. CATTOIR L, Van Hoecke F, Van Maerken T, Nys E, et al
    Hepatitis E virus serology and PCR: does the methodology matter?
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3395.
    PubMed     Text format     Abstract available
    
    
    April 2017
32. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
    Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
    PubMed     Text format     Abstract available
    
    
    
33. MORSICA G, Andolina A, Merli M, Messina E, et al
    NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B.
    Arch Virol. 2017 Apr 18. doi: 10.1007/s00705-017-3341.
    PubMed     Text format     Abstract available
    
    
    March 2017
34. HAMZA H, Abd-Elshafy DN, Fayed SA, Bahgat MM, et al
    Detection and characterization of hepatitis A virus circulating in Egypt.
    Arch Virol. 2017 Mar 16. doi: 10.1007/s00705-017-3294.
    PubMed     Text format     Abstract available
    
    
    
35. CASTELAIN S, Descamps V, Brochot E, Helle F, et al
    High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients.
    Arch Virol. 2017 Mar 13. doi: 10.1007/s00705-017-3312.
    PubMed     Text format     Abstract available
    
    
    February 2017
36. BENSALEM A, Selmani K, Narjes H, Bencherifa N, et al
    Widespread geographical disparities in chronic hepatitis B virus infection in Algeria.
    Arch Virol. 2017 Feb 24. doi: 10.1007/s00705-017-3284.
    PubMed     Text format     Abstract available
    
    
    
37. MUGOSA B, Cella E, Lai A, Lo Presti A, et al
    Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.
    Arch Virol. 2017 Feb 13. doi: 10.1007/s00705-017-3224.
    PubMed     Text format     Abstract available
    
    
    
38. SPITZ N, Moreira AS, Mello FC, Franz HC, et al
    Complete genome sequence of a hepatitis B virus isolate of genotype D2, subtype adrq+, from Brazil.
    Arch Virol. 2017 Feb 8. doi: 10.1007/s00705-017-3269.
    PubMed     Text format     Abstract available
    
    
    
39. NICZYPORUK JS
    Molecular characterisation of fowl adenovirus type 7 isolated from poultry associated with inclusion body hepatitis in Poland.
    Arch Virol. 2017 Feb 3. doi: 10.1007/s00705-017-3240.
    PubMed     Text format     Abstract available
    
    
    November 2016
40. PISANO MB, Balderramo D, Wassaf MM, Lotto M, et al
    Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
41. PURDY MA, Sue A
    The effect of phylogenetic signal reduction on genotyping of hepatitis E viruses of the species Orthohepevirus A.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
42. SANTANA LC, Mantovani NP, Ferreira MC, Arnold R, et al
    Identification of a new hepatitis B virus recombinant D2/D3 in the city of Sao Paulo, Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
43. ZHANG Z, Zhang Y, Xu N, Huang C, et al
    High risk of occult hepatitis B virus infection in leukemia patients from China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
44. ANDRADE AP, Pacheco SD, Silva FQ, Pinheiro LM, et al
    Characterization of hepatitis B virus infection in illicit drug users in the Marajo Archipelago, northern Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
45. SEDIGHIMEHR P, Irani S, Sakhaee F, Vaziri F, et al
    IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
46. NOBLE CF, Malta F, Lisboa-Neto G, Gomes-Gouvea MS, et al
    Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
47. HELALY GF, Elsheredy AG, El Basset Mousa AA, Ahmed HK, et al
    Seronegative and occult hepatitis C virus infections in patients with hematological disorders.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
48. ZAGHLOUL H, El Morsi AA, Soweha HE, Elsayed A, et al
    A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
49. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
50. TAKAHASHI M, Kobayashi T, Tanggis, Jirintai S, et al
    Production of monoclonal antibodies against the ORF3 protein of rat hepatitis E virus (HEV) and demonstration of the incorporation of the ORF3 protein into enveloped rat HEV particles.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
51. MEHTA M, Hetta HF, Abdel-Hameed EA, Rouster SD, et al
    Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
52. JONES LR, Sede M, Manrique JM, Quarleri J, et al
    Hepatitis B virus resistance substitutions: long-term analysis by next-generation sequencing.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
53. GOLSAZ-SHIRAZI F, Mohammadi H, Amiri MM, Khoshnoodi J, et al
    Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
54. DE CONTO F, Medici MC, Ferraglia F, Pinardi F, et al
    Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
55. DI PROFIO F, Melegari I, Sarchese V, Robetto S, et al
    Detection and genetic characterization of hepatitis E virus (HEV) genotype 3 subtype c in wild boars in Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
56. PISANO MB, Blanco S, Carrizo H, Re VE, et al
    Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
57. ABDELRAHEEM WM, Hassuna NA, Abuloyoun SM, Abdel Ghany HM, et al
    Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
58. EL-BENDARY M, Hawas S, El-Hammady D, Al-Hadidy AM, et al
    Profile of expression of certain markers of apoptosis in chronic hepatitis C and hepatitis B patients in an Egyptian population.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
59. CHOI JW, Jung JY, Lee JI, Lee KK, et al
    Molecular characteristics of a novel strain of canine minute virus associated with hepatitis in a dog.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
60. GASPARETO KV, Ribeiro RM, de Mello Malta F, Gomes-Gouvea MS, et al
    HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
61. KONG L, Li S, Yu X, Fang X, et al
    Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
62. BASTANI MN, Bokharaei-Salim F, Keyvani H, Esghaei M, et al
    Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
63. GONG T, Zhao X, Luo Y, Hong Y, et al
    Distribution of hepatitis C virus genotypes in volunteer blood donors from Chengdu, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    March 2016
64. DE SEIXAS SANTOS NASTRI AC, de Mello Malta F, Diniz MA, Yoshino A, et al
    Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    February 2016
65. ZHANG Y, Cheng J, Liu C
    The unique role of the hepatitis virus B X protein on HEK 293 cell morphology and cellular change.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
66. DI BARTOLO I, De Sabato L, Marata A, Martinelli N, et al
    Serological survey of hepatitis E virus infection in farmed and pet rabbits in Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
67. JOVANOVIC-CUPIC S, Glisic S, Stanojevic M, Nozic D, et al
    The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    
68. GALANI BR, Sahuc ME, Sass G, Njayou FN, et al
    Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available
    
    
    December 2015
69. SEGGEWISS N, Kruse HV, Weilandt R, Domsgen E, et al
    Cellular localization and effects of ectopically expressed hepatitis A virus proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available
    
    
    
70. IKEZAKI H, Furusyo N, Hiramine S, Ura K, et al
    Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available
    
    
    
71. LI WY, Ren JH, Tao NN, Ran LK, et al
    The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available
    
    
    November 2015
72. HERNANDEZ S, Jimenez G, Alarcon V, Prieto C, et al
    Replication of a chronic hepatitis B virus genotype F1b construct.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available
    
    
    
73. LIN SL, Cong RC, Zhang RH, Chen JH, et al
    Circulation and in vivo distribution of duck hepatitis A virus types 1 and 3 in infected ducklings.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available
    
    
    October 2015
74. HADIJI-ABBES N, Mihoubi W, Martin M, Karakasyan-Dia C, et al
    Characterization of C69R variant HBsAg: effect on binding to anti-HBs and the structure of virus-like particles.
    Arch Virol. 2015;160:2427-33.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: